Revista do Instituto de Medicina Tropical de São Paulo · 2004 · 69 citations · 10 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyMycologyAntifungal AgentsAntifungal ResistanceAntifungal TherapyAntimicrobial Susceptibility TestingFungal InfectionsFungal PathogenesisAntifungal Drug ResistanceAntifungal Susceptibility TestingAntifungal TreatmentsBroth MicrodilutionCandida Albicans InfectionCandidiasis Drug ResistanceInvasive Fungal InfectionsTertiary Care Organization
Recent studies have shown differences in the epidemiology of invasive infections caused by Candida species worldwide. In the period comprising August 2002 to August 2003, we performed a study in Santa Casa Complexo Hospitalar, Brazil, to determine Candida species distribution associated with candidemia and their antifungal susceptibility profiles to amphotericin B, fluconazole and itraconazole. Antifungal susceptibility was tested according to the broth microdilution method described in the NCCLS (M27A-2 method). Only one sample from each patient was analyzed (the first isolate). Most of the episodes had been caused by species other than C. albicans (51.6%), including C. parapsilosis (25.8%), C. tropicalis (13.3%), C. glabrata (3.3%), C. krusei (1.7%), and others (7.5%). Dose-dependent susceptibility to itraconazole was observed in 14.2% of strains, and dose-dependent susceptibility to fluconazole was found in 1.6%. Antifungal resistance was not found, probably related to low use of fluconazole. Further epidemiological surveillance is needed.
10
Michael A. Pfaller, Daniel J. Diekema, Ronald N. Jones et al. · Journal of Clinical Microbiology · 2001 · 523 citations · Full text
Michael A. Pfaller, Ronald N. Jones, Gary V. Doern et al. · Antimicrobial Agents and Chemotherapy · 2000 · 377 citations · Full text
Arnaldo Lopes Colombo, John R. Perfect, Mark J. DiNubile et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2003 · 127 citations